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ABSTRACT 
Key Points: 
1. Systemic virus infection leads to rapid disruption of the Peyer’s patches but not of 
peripheral lymph nodes.
2. Virus-associated innate immune activation and type I interferon release blocks 
trafficking of B cells to Peyer’s patches.
Early in the course of infection, detection of pathogen-associated molecular patterns by 
innate immune receptors can shape the subsequent adaptive immune response. Here we 
investigate the influence of virus-associated innate immune activation on lymphocyte 
distribution in secondary lymphoid organs. We show for the first time that virus infection of 
mice induces rapid disruption of the Peyer’s patches but not of other secondary lymphoid 
organs. The observed effect was not dependent on an active infectious process but due to 
innate immune activation and could be mimicked by virus-associated molecular patterns 
such as the synthetic double-stranded RNA poly(I:C). Profound histomorphological changes 
in Peyer’s patches were associated with depletion of organ cellularity, most prominent 
among the B cell subset. We demonstrate that the disruption is entirely dependent on type I 
interferon. At the cellular level, we show that virus-associated immune activation by IFN-α
blocks B-cell trafficking to the Peyer’s patches by downregulating expression of the homing 
molecule α4β7-integrin. In summary, our data identify a mechanism that results in type I IFN-
dependent rapid but reversible disruption of intestinal lymphoid organs during systemic viral 
immune activation. We propose that such re-routed lymphocyte trafficking may impact the 
development of B cell immunity to systemic viral pathogens. 
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INTRODUCTION 
The innate immune system represents the first line of defense against invading viruses. The 
initiation of an anti-viral response is critically dependent on the detection of specific 
pathogen-associated molecular patterns by innate immune pattern-recognition receptors.1
These patterns are evolutionarily highly conserved molecular structures shared by a variety 
of different viruses. One such pattern is viral RNA, which can be detected by members of the 
retinoic acid inducible gene I (RIG-I)-like receptor and Toll-like receptor (TLR) families.2,3
Activation of these receptors leads to the initiation of an innate immune response 
characterized by the rapid production of pro-inflammatory cytokines such as the type I 
interferons (IFN) IFN-α and IFN-β. At the infected site, type I IFNs act in concert with other 
cytokines to hinder the replication and spread of virus and to recruit inflammatory cells. In 
addition, these cytokines have systemic effects that can critically shape the subsequent 
adaptive immune response.4
Adaptive immunity depends on lymphocyte maturation in primary lymphoid organs, their 
tightly regulated release into the circulation and accurate positioning in secondary lymphoid 
organs. Several reports have recently highlighted the impact of virus-associated type I IFNs 
on lymphocyte development and distribution: In bone marrow, dormant hematopoietic stem 
cells that give rise to virtually all leukocytes have been shown to enter the cell cycle after 
intravenous injection of type I IFNs and during virus infection.5 We and others have 
demonstrated that activation of virus-sensing innate immune receptors with the synthetic 
double-stranded RNA poly(I:C) leads to type I IFN-dependent rapid involution of the 
thymus. 6 In skin-draining peripheral lymph nodes (PLN), poly(I:C)-induced type I IFNs have 
been shown to block lymphocyte egress which results in temporary lymphoid organ 
‘shutdown’.7 However, little is known about the influence of virus infection on lymphocyte 
distribution in secondary lymphoid organs of the intestinal immune compartment. 
Many viruses, including those classically considered non-enteric, frequently show intestinal 
involvement, either due to direct infection of the gut mucosa or to collateral effects.8 In the 
course of such an enteric infection, aggregated lymphoid follicles in the gut wall - the Peyer’s 
patches - form the primary inductive site of intestinal anti-microbial immunity.9,10 In this study, 
we investigated the effect of virus-associated innate immune activation on lymphocyte 
distribution within these organs. Here we show for the first time that viral immune activation 
substantially changes the morphology of the Peyer’s patches by inducing their rapid 
disruption. A marked type I IFN-dependent loss of cellularity was associated with strongly 
reduced B cell trafficking to the Peyer’s patches. Our data identify a mechanism that results 
in rapid but reversible loss of B cells in Peyer’s patches during virus-associated systemic 
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innate immune activation. We hypothesize that such re-routing of lymphocyte trafficking 
during systemic infection may be important for effective anti-viral B cell immunity.   
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METHODS 
Mice. Female C57BL/6 mice were purchased from Harlan-Winkelmann and Janvier. Type I 
IFN receptor-deficient mice (IFNaR-/-) were backcrossed 20 times on the C57BL/6 
background 11. Mice were at least 8 weeks of age at the onset of experiments. All animal 
studies were approved by the local regulatory agency (Regierung von Oberbayern, Munich, 
Germany). 
Injection of poly(I:C), recombinant IFN-α, virus and blocking antibody. Mice were 
injected i.p. with poly(I:C) (InvivoGen) (250 g in PBS). For examination of lymphoid organ 
cellularity, mice were treated twice at a 3-day interval. In all other experiments, mice were 
treated with a single injection of poly(I:C). Where indicated, mice were provided with drinking 
water supplemented with FTY720 (Sigma, 2 g/ml) beginning two days prior to the first 
poly(I:C) treatment. IFN-α (Miltenyi) was applied i.p. (12 g in 200 l PBS) daily on 6 
consecutive days. 24 h after the last injection, lymphoid organs were examined. For viral 
infection, mice were i.p. injected with 106 pfu of VSV Indiana strain in 200 l PBS. Lymphoid 
organs were examined 2 or 5 days after virus injection. For in vivo-α4β7-blockade, mice were 
injected i.p. with 75 μg anti-α4β7 antibody (clone DATK32) or a rat IgG2a control antibody 
(AbD Serotec, Puchheim, Germany) in 100 μl PBS. Purification of DATK32 antibody from the 
DATK32 hybridoma cell line (ATCC, Manassas, USA) is described in detail in the 
Supplementary Material and Methods. 
Tissue preparation. Tissue single cell suspensions were prepared as described 
previously.12 For the determination of lymphocyte numbers in secondary lymphoid organs, 
bilateral inguinal and axillary lymph nodes were pooled (PLNs). For mesenteric lymph nodes, 
all lymph nodes along the full length of the superior mesenteric artery to the aortic root were 
dissected as described.13 All Peyer’s patches were prepared and were pooled for further 
analysis. Isolation of lymphocytes from small intestine lamina propria was performed as 
described previously.14 Briefly, small intestine was removed 0.5 cm below stomach and 1 cm 
above cecum. Peyer’s patches were removed surgically. The intestine was opened 
longitudinally and cut into pieces of 0.5-1 cm in length. Epithelial cells and intraepithelial 
lymphocytes were detached by several washing steps with HBSS containing 1 mM DTT or 
1.3 mM EDTA. Pieces of small intestine were then enzymatically digested with the help of 
collagenase VIII (Sigma). Single cell suspensions were purified using 44%-67% percoll 
(Sigma) gradient centrifugation.
Flow cytometry. Antibodies to CD3 (Clone: 17A2), CD4 (RM4-5), CD8 (53-6.7), CD11c 
(N418), CD19 (6D5), CD69 (H1.2F3), α4β7 (DATK32) and CD62L (MEL-14) were purchased 
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from BioLegend. Antibodies to Foxp3 (FJK-16a) and S1P1 (713412) were from Ebioscience 
and R&D Systems. Cells were stained in PBS supplemented with 10% FCS and were 
analyzed using a FACSCanto II (BD Biosciences). For intracellular staining, single-cell 
suspensions were fixed and permeabilized using a ready-mixed kit from Ebioscience. 
Fluorescence associated with non-specific binding was subtracted using subtype-specific 
isotype controls. All data were evaluated with FlowJo software (Treestar).  
Histology and immunohistochemistry. For regular histology specimens were fixed in 
formalin before embedding in paraffin blocks. Tissue sections were stained with Hematoxylin 
and Eosin (H&E). Images were obtained using light microscopy. For immunohistochemistry 
tissue was deep-frozen in OCT and cryosections of 5 m were prepared and fixed with ice-
cold acetone. Sections were rehydrated with PBS and blocking was performed using 10 % 
goat-serum in PBS. For fluorescent labeling unconjugated anti-B220 (RA3-6B2, Biolegend) 
primary antibody, followed by anti-rat IgG Cy3-conjugated antibody (112-165-1430, Jackson 
ImmunoResearch) and DAPI (Biotium) for counterstaining were used. Pictures were taken 
with a standard fluorescent microscope and processed with Adobe Photoshop to adjust size. 
Cell purification and adhesion assay. B cells from different secondary lymphoid organs 
were enriched using a MACS CD19+ B cell isolation kit according to the manufacturer’s 
protocol (Miltenyi Biotech). Purity of magnetically sorted B cells was > 95 %. 96-well plates 
were coated with recombinant mouse MAdCAM-Fc chimera (10 g/ml, R&D Systems) 
overnight at 4 °C. The supernatant was then discarded and wells blocked with 1 % BSA in 
PBS for 3 h at room temperature. Purified B cells were cultured in RPMI 1640 medium 
supplemented with 10% FCS, 2 mM L-glutamine, 100 μg/mL streptomycin, and 1 IU/mL 
penicillin (complete RPMI) in the presence of recombinant IFN-α (1x103 U/ml). B cells were 
labeled with CFSE (Invitrogen) according the manufacturer’s protocol. Cells (107/ml in DMEM 
without phenol red supplemented with 25 mM HEPES) were pre-incubated in polypropylene 
tubes with or without DATK32, MEL-14 or M17/4 antibody (10 g/ml, all from BioLegend) for 
25 min at 37 °C before cells were added to coated plates and incubated for 35 min at 37 °C 
and 5 % CO2. Non-adherent cells were removed by 2 to 3 washing steps with PBS. 
Fluorescent emission of adhesive cells was measured with a plate reader. 
In vivo homing experiments. Splenic B cells were cultured in complete RPMI with or 
without added IFN-α (1x103 U/ml) for 24 h. Subsequently, the two cell cultures were stained 
with CFSE or Cell Tracker violet (both 5 M, Molecular Probes) according to the 
manufacturer’s protocol. 1 x 107 cells from each preparation were mixed and injected i.v. into 
naïve recipient mice. An aliquot was saved to assess the input ratio. 6 hours after the 
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adoptive transfer, cell preparations from different recipient tissues were analyzed for 
adoptively transferred B cells by flow cytometry. The homing index (HI) was calculated as the 
ratio of [IFN-α B cells]tissue / [untreated B cell]tissue to [IFN-α B cells]input / [untreated B cell]input
as described previously.15
Serum IgA levels. For the analysis of total serum immunoglobulin (Ig) G and IgA levels, 96-
well plates (Nunc) were coated with goat anti-mouse IgA or goat anti-mouse IgG (Southern 
Biotech). For detection peroxidase-linked anti-mouse alpha-chain or gamma-chain specific 
secondary antibody (Sigma) and TMB substrate kit (BD Bioscience) were used.  
Statistics. All data are presented as mean ± S.E.M. Statistical significance of single 
experimental findings was assessed with the independent two-tailed Student’s t-test. For 
multiple statistical comparison of a data set the one-way ANOVA test with Bonferroni 
post-test was used. Significance was set at P values < 0.05, p < 0.01 and p < 0.001 and was 
then indicated with an asterisk (*, ** and ***). All statistical calculations were performed using 
Graphpad Prism (GraphPad Software). 
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RESULTS 
Virus-associated immune activation causes rapid disruption of Peyer’s patches. 
To examine the effect of virus infection on the distribution of lymphocytes in intestinal 
lymphoid organs, we injected mice intraperitoneally with the negative strand RNA virus 
vesicular stomatitis virus (VSV). This model is characterized by rapid viral spread to multiple 
body compartments and high systemic levels of type I IFN induction.16 On inspection of the 
small intestine, the Peyer’s patches of VSV-infected mice showed pronounced reduction in 
organ size that was due to a loss in cellularity (Fig. 1A). A similar disruption was observed 
when mice were treated with poly(I:C), a synthetic double-stranded RNA analog. Poly(I:C) 
mimics a viral molecular pattern and stimulates the innate immune system through the 
activation of the Toll-like receptor 3 and the family of RIG-like helicases.2,3 Adult mice were 
injected twice intraperitoneally with poly(I:C) at a 3-day interval and organs were examined 
48 h after the second injection. The total number of Peyer’s patches was markedly reduced 
in poly(I:C)-treated mice and the remaining Peyer’s patches were macroscopically barely 
visible. On average, less than two Peyer’s patches were identified in poly(I:C)-treated vs. 
eight Peyer’s patches or more in untreated mice (Fig. 1B). The cell numbers in Peyer’s 
patches dropped by more than 70 %. In contrast, in mesenteric lymph nodes or skin-draining 
PLN cellularity remained unchanged after poly(I:C) treatment (Fig. 1C). Morphologically, the 
Peyer’s patches are formed by aggregated lymphoid follicles surrounded by the corona or 
subepithelial dome.17 To assess changes in Peyer’s patch microanatomy, organs from 
poly(I:C)-treated mice were examined histologically. The sections showed striking changes in 
the Peyer’s patch architecture: Lymphoid follicles were barely visible and the width of the 
subendothelial dome was markedly reduced (Fig. 1D). This effect was independent of the 
injection route of poly(I:C) as the disruption of the Peyer’s patches did not differ when 
poly(I:C) was applied intravenously instead of intraperitoneally (Fig. S1).
In the remaining Peyer’s patches, the poly(I:C)-induced loss of cellularity affected all 
lymphocyte subsets (Fig. 2A). However, the effect was most prominent among B cells which 
form the most abundant lymphocyte population in these lymphoid organs.17 Indeed, the 
overall frequency of B cells within the Peyer’s patches dropped by 37 ± 14 % whereas other 
cell types showed constant frequencies (Fig. 2B). In contrast, in PLN the absolute number 
and frequency of B cells were increased following poly(I:C) treatment (Fig. 2C+D). Because 
the observed loss of cellularity was mainly due to decreased B cell numbers, we focused our 
following work on this subset. 
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Disruption of the Peyer’s patches is dependent on type I interferons. 
In the mammalian anti-viral immune response, the release of type I interferon plays a central 
role. Activation of pattern-recognition receptors by poly(I:C) leads to the production of a large 
amount of the type I interferons IFN-α and IFN-β which both signal through the IFN-α
receptor (IFNaR).18 To investigate the role of type I IFN in poly(I:C)-induced disruption of the 
Peyer’s patches, we treated IFNaR-deficient mice (IFNaR-/-) with poly(I:C). In contrast to the 
reduced cellularity in Peyer’s patches of wild-type mice, IFNaR-/- mice showed no change in 
cell numbers in these organs following poly(I:C) treatment (Fig. 3A). Furthermore, treatment 
of mice with recombinant IFN-α also led to the disruption of Peyer’s patches, demonstrating 
a direct involvement of type I IFN (Fig. 3B). Two essential mechanisms by which type I IFN 
can prevent viral replication are the induction of apoptosis19 and the suppression of 
proliferation in host cells.20 To investigate whether these mechanisms were involved in the 
disruption of Peyer’s patches, we first quantified B cell proliferation by measuring their in vivo
incorporation of BrdU. Following poly(I:C) treatment, we observed an increased B cell 
proliferation in the spleen but no changes within Peyer’s patches or PLN (Fig. S2A). To 
evaluate the role of apoptosis in the disruption of Peyer’s patches, we determined the 
percentage of apoptotic B cells within lymphoid organs upon treatment with poly(I:C). 
Surprisingly, early apoptotic B cells were slightly reduced in both PLN and Peyer’s patches 
whereas there was little increase in late apoptotic B cells in Peyer’s patches (Fig. S2B).
Taken together, these data show that the disruption of the Peyer’s patches following poly(I:C) 
treatment is dependent on type I IFN but cannot be explained by changes in B cell 
proliferation or apoptosis. 
Treatment of mice with the S1P1-blocking agent FTY720 counteracts immune-induced 
disruption of the Peyer’s patches. 
Previous reports have demonstrated that the sphingosine-1 phosphate receptor 1 (S1P1) is 
essential for lymphocyte recirculation and that it regulates egress from both thymus and 
peripheral lymphoid organs.21 Following poly(I:C) treatment, type I IFN has been shown to 
induce lymphocyte expression of CD69 which forms a complex with and thus negatively 
regulates S1P1, resulting in reduced T and B cell efflux from PLN and their accumulation in 
these lymph nodes.7 Based on our novel findings that organ cellularity increases in PLN but 
decreases in Peyer’s patches following innate immune activation, we hypothesized that 
S1P1-dependent B cell efflux from these tissues might be regulated in opposite ways. Thus, 
the poly(I:C)-induced disruption of Peyer’s patches could be caused by an enhanced B cell 
egress from these organs. To investigate whether B cell efflux from Peyer’s patches is 
increased during innate immune activation, mice were injected twice with poly(I:C) following 
pretreatment with FTY720. This immunosuppressant drug has been shown to inhibit 

ht
tp
://
do
c.
re
ro
.c
h
lymphocyte emigration from lymphoid organs by downregulating S1P1.21 FTY720 treatment 
alone did not significantly change absolute cell numbers in Peyer’s patches or PLN (Fig. 4).
Strikingly, mice that were pretreated with FTY720 did not show reduced cellularity of Peyer’s 
patches following two injections of poly(I:C). Thus, FTY720 treatment counteracts the 
poly(I:C)-induced disruption of Peyer’s patches. In view of the known effect of FTY720 on 
S1P1-mediated lymphocyte migration, we concluded that the disruption might be due to 
increased S1P1-dependent lymphocyte egress. 
Stimulation with type I interferon results in reduced B cell homing to Peyer’s patches. 
To test this hypothesis, we compared S1P1 mRNA levels in B cells from PLN and Peyer’s 
patches following poly(I:C) treatment. In line with with previous reports,7 S1P1 transcripts
were rapidly reduced in B cells from PLN (Fig. S3A). However, B cells in Peyer’s patches 
also showed downregulated S1P1 mRNA levels after poly(I:C) treatment. Flow cytometry 
analysis confirmed that B cells in both PLN and Peyer’s patches showed similarly reduced 
expression of S1P1 after injection of poly(I:C) (Fig. S3B). As described previously21, the 
reduced expression of S1P1 on B cells from PLN of poly(I:C)-treated mice translated into 
impaired B cell ability to migrate towards a S1P gradient in vitro (Fig. S3C). B cells prepared 
from Peyer’s patches of poly(I:C)-treated mice showed similarly reduced in vitro-chemotaxis 
towards S1P. Taken together, these data demonstrate that following poly(I:C) treatment, 
B cells in Peyer’s patches do not show an increase but rather a decrease in S1P1-dependent 
migration, similar to the reduced migration described for B cells in PLN.21 Hence, the striking 
difference in cellularity of Peyer’s patches and PLN in poly(I:C)-treated mice is unlikely to be 
due to opposite regulation of S1P1-dependent lymphocyte egress.  
Previous reports highlighted that FTY720 not only affects S1P1-dependent egress of 
lymphocytes but also enhances their homing into secondary lymphoid organs.22 We therefore 
hypothesized that poly(I:C) and type I interferon cause disruption of Peyer’s patches by 
decreasing the entry of B cells into these organs and that this mechanism is counteracted by 
FTY720. Lymphocyte homing is guided by a pattern of site-specific surface molecules such 
as integrins that direct them to different tissue compartments. The integrin α4β7 is essential 
for lymphocyte entry into Peyer’s patches and the intestinal lamina propria through 
interaction with its ligand, the mucosal addressin cell adhesion molecule-1 (MAdCAM-1), 
which is locally expressed on specialized high endothelial venules in these tissues.23-25 At the 
same time lymphocytes express CD62L (L-Selectin) which allows for their influx into PLN26
but also plays a role in their migration to Peyer’s patches.27 To investigate whether type I 
IFN-dependent disruption of Peyer’s patches might be due to reduced B cell entry into these 
lymphoid organs, we first determined the expression of the adhesion molecules α4β7 and 
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CD62L on IFN-α-treated splenic B cells.  IFN-α-activated B cells showed increased 
expression of the early activation marker CD69 and moderately increased levels of CD62L 
but downregulated surface expression of the gut-homing integrin α4β7 (Fig. 5A). Consistent 
with these findings, IFN-α-stimulated B cells showed reduced in vitro-binding to MAdCAM-1 
(Fig. 5B). This reduction was comparable to that seen with an α4β7-blocking antibody. 
Pretreatment with antibodies that inhibit the adhesion molecules CD62L or LFA-1 did not 
influence B cell adhesion to recombinant MAdCAM-1.  
The modified expression pattern of adhesion molecules and binding characteristics of the 
IFN-α-activated B cells translated into an essentially altered in vivo homing behavior. 
Following adoptive transfer into naïve recipient mice, IFN-α-activated B cells showed 
reduced immigration into Peyer’s patches when compared to co-transferred unstimulated 
cells (Fig. 5C). In contrast, IFN-α pretreatment increased B cell migration to PLN. Homing to 
spleen was not influenced by IFN-α activation. Taken together, these data demonstrate that 
IFN-α downregulates expression of the gut-homing molecule α4β7 and selectively blocks 
B-cell trafficking to the Peyer’s patches. Thus, we conclude that poly(I:C) and type I 
interferon-induced disruption of the Peyer’s patches is caused by a reduced influx of B cells 
into the Peyer’s patches. Indeed, acute blockade of α4β7 function in vivo following a single 
injection of anti-α4β7 antibody led to rapid loss of Peyer’s patch cellularity (Fig. 5D), whereas 
cell numbers in spleen and peripheral lymph nodes were not significantly altered. Thus, the 
changes in organ cellularity induced by α4β7 blockade mirror the effects of poly(I:C)-mediated 
type I IFN release. 
Previous reports have demonstrated that expression of the α4β7 integrin is not only important 
for B-cell entry into Peyer’s patches but also for their trafficking to the intestinal lamina 
propria; this being a prerequisite for the effective clearance of an intestinal virus infection.28
Therefore, we investigated whether downregulation of α4β7 following virus-associated innate 
immune activation has an impact on lymphocyte distribution in the intestinal lamina propria. 
Repetitive treatments with poly(I:C) did not influence lymphocyte numbers nor their 
localization within the small intestine lamina propria (Fig. 6A,B). Compatibly, serum levels of 
IgA, that is predominantly associated with mucosal immunity, were not altered following 
poly(I:C) treatment (Fig. 6C).
Disruption of the Peyer’s patches is a self-limiting process. 
Upon viral infection or stimulation by synthetic ligands such as poly(I:C), the secretion of type 
I IFN is typically an early and short-lasting event.29 As the Peyer’s patch loss in cellularity is 
dependent on type I interferons, we examined whether the effect is reversible upon 
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termination of IFN-inducing poly(I:C) treatment. Therefore, we examined α4β7 and CD69 
expression following a single injection of poly(I:C) on circulating B cells which give rise to the 
Peyer’s patches B cell population. And indeed the downregulation of the gut-homing integrin 
α4β7 observed on B cells after poly(I:C) treatment peaked around 12 h and was restored to 
baseline level 96 h post injection (Fig. 7A, B). Interestingly, this process occured 
simultaneously with the upregulation of the activation marker CD69 which has been shown to 
bind and negatively regulate S1P1.7 In line with the transient α4β7 downregulation, diminished 
cellularity of the Peyer’s patches induced by two consecutive poly(I:C) treatments had 
returned to baseline levels 20 days after the last injection (Fig. 7C). These data suggest that 
immune-induced disruption of Peyer’s patches is self-limiting and that organ integrity is 
restored after cessation of viral innate immune activation. 
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DISCUSSION 
The disruption of Peyer’s patches observed in our study is reminiscent of the changes 
described in mice that genetically lack the adhesion molecule β7 integrin or its regulating 
transcription factor, Kruppel-like factor 2.30,31 These mice are characterized by smaller 
numbers of Peyer’s patches and reduced cellularity within these organs compared to wild-
type mice. Furthermore, we show a similar phenotype after a single injection of a neutralizing 
antibody against α4β7 resulting in a rapid and strong decrease in the cellularity of Peyer’s 
patches. In transfer experiments, we have shown that IFN-α stimulation selectively impairs 
migration of B cells to Peyer’s patches, whereas recirculation to PLNs is moderately 
increased. This homing pattern mimics the migratory capacity of lymphocytes that either 
genetically lack the β7 subunit or have been treated with neutralizing antibodies against the 
α4β7 heterodimer or its subunits.24,30,32 Indeed, we demonstrate that IFN-α-activated B cells 
downregulate the integrin heterodimer α4β7 and that this is associated with reduced binding 
to its endothelial ligand MAdCAM-1. In contrast to the impaired homing to the Peyer’s 
patches, β7-deficient lymphocytes have been described to show only little change in 
recirculation to mesenteric or peripheral lymph nodes. This is due to the redundant activity of 
the adhesion molecule CD62L, which can partly compensate for the absence of α4β7.33
Compatibly, we observed a moderately increased expression of CD62L following virus-
associated innate immune activation and stable B cell numbers in mesenteric and peripheral 
lymph nodes. We also observed that B cell distribution within the intestinal lamina propria, 
which is also dependent on the α4β7 integrin, was not altered following virus-associated 
innate immune activation. In general, the changes in B-cell trafficking to GALT following viral 
immune activation show parallels to the recently observed modifications in the homing of 
bystander-activated CD8 T cells during acute bacterial infection. 34
Disruption of the Peyer’s patches was prevented when mice were pretreated with the 
immunomodulatory compound FTY720, which was initially described to block S1P1-
dependent lymphocyte egress from thymus and peripheral lymph nodes.21 However, after 
poly(I:C) immune activation we did not observe increased B cell responsiveness to S1P in 
Peyer’s patches, which could have accounted for reduced organ cellularity and disruption. 
Thus, the prevention of Peyer’s patch disruption associated with FTY720 was unlikely to 
stem from a blockage of B cell egress from secondary lymphoid organs. Indeed, a later study 
suggested that, in addition to its effect on lymphocyte egress, FTY720 can reinforce 
lymphocyte interactions with high endothelial venules and thus rescue the immigration 
defects of β2 or β7 integrin single-deficient lymphocytes into secondary lymphoid organs.35
Thereby, FTY720 treatment does not activate alternative homing mechanisms but rather 
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seems to shift the balance of distinct molecular mechanisms during the extravasation 
process by extending the retention time of the lymphocytes on the endothelial surfaces. We 
suggest that the absence of Peyer’s patches disruption in FTY720-pre-treated mice is due to 
reinforced lymphocyte-endothelium interactions that compensate for reduced B cell α4β7
expression upon poly(I:C) injection. In line with previous reports,21 we found that 
administration of FTY720 led to pronounced lymphopenia, which is however not expected to 
significantly impact homeostatic lymphocyte homing to the Peyer’s patches.36
Interestingly, we found that reduced B cell expression of α4β7 and associated disruption of 
Peyer’s patches is self-limiting and that lymphoid organ cell numbers return to baseline levels 
once the systemic immune activation induced by virus-associated molecular patterns has 
ceased. Such transient modulation of factors that influence homeostatic trafficking and 
motility of lymphocytes has been suggested as a mechanism of the adaptive immune 
response to orchestrate local cellularity, thus limiting competition for space and resources 
during ongoing immune responses.37 Indeed, Mueller et al. demonstrated that during viral 
infection certain chemokines which guide lymphocyte migration into lymphoid organs can be 
downregulated, thereby shaping the specificity of the newly generated memory cell pool. Our 
findings show two new aspects of this concept: a) that not only chemokines but also integrins 
participate in these regulatory mechanisms and b) trafficking of newly activated non-cognate 
lymphocytes can be controlled in a tissue-specific manner. 
During systemic infection, the type I IFN-dependent transient re-routing of B cell trafficking 
may also serve to redirect a polyclonal population of B cells to the systemic circulation where 
antigens are present. Indeed, systemic infection of mice with murine leukaemia viruses leads 
to a dramatic enlargement of spleen and lymph nodes that is associated with atrophy of the 
Peyer’s patches and a predominant B cell loss.38 Oral infection with rotavirus, a pathogen 
with gastrointestinal tropism, leads to hyperplasia of the Peyer’s patches in mice10,39. In this 
model of intestinal infection, local proliferation of antigen-specific B and T cells in the Peyer’s 
patches may block or simply mask reduction in non-cognate B cells.28,40 During chronic virus 
infections, prolonged type I IFN release has been associated with hyperimmune activation, 
disruption of lymphoid tissue architecture and disease progression.41,42 It is thus possible that 
during chronic immune activation, prolonged changes in B cell homing patterns may in fact 
hinder the control of virus replication. Generally, understanding the regulation of lymphocyte 
distribution during viral immune activation may open new possibilities for the treatment of 
associated immune pathologies. In addition, potent synthetic inducers of type I IFN such as 
poly(I:C) have evolved as a promising tool to modulate the immune system for therapeutic 
purposes 43. Recombinant type I interferons are commonly used for the treatment of cancer 
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and chronic viral infections such as hepatitis.44,45 Such therapeutic utilization of highly-
concentrated type I IFN could affect Peyer’s patch cellularity in humans and thus their impact 
on intestinal immune function should be considered, especially in the case of chronic 
regimens.  
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FIGURE LEGENDS 
Figure 1: Virus-associated immune activation causes rapid disruption of Peyer’s 
patches. (A) Mice were infected with vesicular stomatitis virus (VSV) and 2 or 5 days later, 
all macroscopically detectable Peyer’s patches were isolated. The total cell count for all 
Peyer’s patches per mouse was determined. (B to D) Mice were treated twice (day 0 and 3) 
with poly(I:C) and organs were examined 48 h after the second injection. (B) Number of 
macroscopically detectable Peyer’s patches per mouse. (C) Mean number of cells in 
lymphoid compartments per mouse. (A to C) Each data point represents one individual 
mouse and the mean of at least n = 4 mice per group is depicted as a bar. All data are 
representative of at least two independent experiments. (D) H&E-stained paraffin sections of 
the small intestine from one untreated and one poly(I:C)-treated mouse. The boxes indicate 
the Peyer’s patches depicted below with 40x magnification. These sections are 
representative of n = 3 mice per group. PLN, peripheral lymph nodes. H&E, hematoxylin and 
eosin 
Figure 2: Disruption of Peyer’s patches is due to a decrease in B cell numbers. Mice 
were treated with poly(I:C) as in Fig. 1. Lymphocyte subpopulations were analyzed by flow 
cytometry. (A) Absolute cell numbers and (B) poly(I:C)-induced change of lymphocyte 
subpopulation frequency within all viable cells (difference to untreated in %) in Peyer’s 
patches and PLN were determined. Data indicate the mean value of n = 5 mice ± S.E.M and 
are representative of at least three independent experiments. Treg, regulatory T cells 
Figure 3: Disruption of the Peyer’s patches is dependent on type I interferons. (A) Mice 
were treated as in Fig. 1 and organs were examined 48 h after the last poly(I:C) injection. 
Cell numbers in Peyer’s patches and PLN of wild-type and IFNaR-deficient (IFNaR-/-) mice 
are shown. Each data point represents one individual mouse and the mean of n = 5 mice per 
group are depicted as a bar. (B) Mice were treated with recombinant IFN-α and organs were 
examined 24 h after the last injection. Cell numbers in Peyer’s patches are shown. Each data 
point represents one individual mouse and the mean of n = 6 mice per group are depicted as 
a bar. Data are representative of two independent experiments. 
Figure 4: Treatment of mice with the S1P1-blocking agent FTY720 counteracts 
immune-induced disruption of the Peyer’s patches. Mice were provided with drinking 
water supplemented with FTY720 and treated with poly(I:C) as in Fig. 1. Organs were 
examined 48 h after the last poly(I:C) injection for absolute cell numbers. Data give the mean 
values of n = 10 mice per group ± S.E.M from two independent experiments.
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Figure 5: Stimulation with type I interferon results in reduced B cell homing to Peyer’s 
patches. Purified splenic B cells were cultured in the presence of recombinant IFN-α for 
24 h. (A) Surface expression of CD69, CD62L and α4β7 was determined by flow cytometry. 
(B) Splenic B cells were either stimulated with IFN-α or treated with adhesion molecule-
blocking antibodies. Binding of the fluorescently labeled cells to plate-bound MAdCAM-1 was 
determined by spectrophotometer. All data give the mean value of triplicate samples ±
S.E.M. (C) IFN-α-stimulated splenic B cells were fluorescently labeled and adoptively 
transferred into naïve recipient mice. 4 h later, recipients were sacrificed and lymphoid 
organs assessed for the presence of transferred B cells. The homing index represents the 
ratio of IFN-α-activated B cells to unstimulated B cells. Data show the mean value of 
individual recipient mice (n = 3) ± S.E.M. The asterisk indicates comparison to the homing 
index for the spleen. (D) Mice were injected i.p. with an anti-α4β7 or an isotype control 
antibody. 24h later, cell numbers in secondary lymphoid organs were determined by flow 
cytometry. Data show the mean value of individual mice (n = 7 for Peyer’s patches and 
spleen, n = 4 for PLN) ± S.E.M pooled from two independent experiments.  All data are 
representative of at least two independent experiments. 
Figure 6: Virus-associated innate immune activation does not alter lymphocyte 
numbers in the intestinal lamina propria. Mice were treated with poly(I:C) as in Figure 1.
(A) Absolute lymphocyte numbers in the intestinal lamina propria were determined by flow 
cytometry. Each data point represents one individual mouse and the mean of n = 5 
poly(I:C)-stimulated and n = 3 untreated mice per group is depicted as a bar. (B) Distribution 
of B220+ B cells (red) in the intestinal lamina propria was analyzed by immunohistochemistry. 
(C) Serum levels of IgA and IgG were determined by ELISA. Each data point represents one 
individual mouse and the mean of n = 10 mice per group is depicted as a bar. All data are 
representative of at least two independent experiments. 
Figure 7: Disruption of the Peyer’s patches is a self-limiting process. (A) Time course of 
α4β7 and CD69 expression on circulating B cells in the peripheral blood after a single injection 
of poly(I:C). Data give the mean value of n = 3 individual mice ± S.E.M. The dashed line 
represents the baseline level of α4β7 expression before treatment. (B) Representative 
histograms are gated on CD19+ blood-borne B cells and give α4β7 and CD69 expression 12 h 
after poly(I:C) treatment (thin grey line, isotype control).  (C) Mice were treated with poly(I:C) 
as in Fig. 1. Time course of total cell numbers in Peyer’s patches after the last injection. Each 
data point represents one individual mouse and the mean of n = 5 mice per group is depicted 
as a bar. All data are representative of at least two independent experiments. Unstim, 
unstimulated.  
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